CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 55 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-02 | Lockshin Curtis Director | Grant or award · Overallotment purchase right | +6,000 | 6,000 | ||
| 2015-06-02 | Lockshin Curtis Director | Grant or award · Common stock warrant | +6,000 | 6,000 | ||
| 2015-06-02 | Dorman H. Paul Director | Grant or award | +37,500 | $0.40 | $15K | 37,500 |
| 2015-06-02 | Dorman H. Paul Director | Grant or award · Overallotment purchase right | +18,750 | 18,750 | ||
| 2015-06-02 | Dorman H. Paul Director | Grant or award · Common stock warrant | +18,750 | 18,750 | ||
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award | +70,000 | $0.40 | $28K | 137,500 |
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award | +10,000 | $0.40 | $4K | 15,000 |
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award · Overallotment purchase right | +35,000 | 35,000 | ||
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award · Common stock warrant | +35,000 | 35,000 | ||
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award · Overallotment purchase right | +5,000 | 5,000 | ||
| 2015-06-02 | CAUWENBERGH GEERT President & CEO | Grant or award · Common stock warrant | +5,000 | 5,000 | ||
| 2015-06-02 | Bitterman Robert J Director | Grant or award | +37,500 | $0.40 | $15K | 44,000 |
| 2015-06-02 | Bitterman Robert J Director | Grant or award · Overallotment purchase rights | +18,750 | 18,750 | ||
| 2015-06-02 | Bitterman Robert J Director | Grant or award · Common stock warrants | +18,750 | 18,750 | ||
| 2015-06-01 | Lockshin Curtis Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2015-06-01 | Dorman H. Paul Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2015-06-01 | Brownlie Keith L Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2015-06-01 | Bitterman Robert J Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2015-06-01 | CAUWENBERGH GEERT President & CEO | Grant or award · Stock option (right to buy) | +133,000 | 133,000 | ||
| 2015-06-01 | Kontulis Caitlin Secretary & Controller | Grant or award · Stock option (right to buy) | +10,000 | 10,000 |
Page 11 of 13 · 258 trades